The Underlying Mechanism of Spinal Manipulative Therapy and the Effect of Pain on Physical Outcome Measures

August 9, 2015 updated by: University of Alberta
The purpose of this study is to compare changes in spinal stiffness and back muscle activity between spinal manipulative therapy (SMT) responders, non-responders and asymptomatic participants. Additionally, the investigators wanted to compare the amount of lumbar degeneration between SMT responders, non-responders and asymptomatic participants. This study also determines if the presence of pain modifies post-SMT spinal stiffness and back muscle activity.

Study Overview

Detailed Description

SMT is a common manual therapy for treating patients with mechanical low back pain (LBP). SMT is defined as a high velocity, low amplitude thrust technique. Specifically, the clinician stands beside a supine patient. The patient is passively side-bent towards the side to be manipulated. The clinician passively rotates the patient and then delivers a high velocity, low amplitude thrust to the anterior superior iliac spine in a posteroinferior direction. SMT is indicated for patients with LBP judged to have spinal hypomobility or malalignment. Recently, our collaborators have discovered that LBP subjects who benefit from SMT can be identified prior to treatment by a five-item clinical prediction rule. Compared to non-responders, those who respond to SMT have: 1) more than 30% decrease in the modified Oswestry Disability Index score, 2) a significant and immediate decrease in spinal stiffness, and 3) a concurrent change in lumbar multifidus muscle activity. Taken together, the physical changes experienced by SMT responders alone provide an unique opportunity to better understand the mechanisms underlying SMT.

Since spinal stiffness is an important physical indicator of SMT response, it is important to understand the causal relation between pain, paraspinal/trunk muscle activity and spinal stiffness. Although research has shown positive correlation between pain and muscle activity, and between paraspinal muscle activity and spinal stiffness, the causal relation between pain, paraspinal/trunk muscle activity and spinal stiffness remains unknown. Given this background, an induction of temporary benign experimental pain to asymptomatic individuals can help clarify such causal relation and improve our understanding of physical responses in responders following pain resolution by SMT.

Study Type

Interventional

Enrollment (Actual)

103

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alberta
      • Edmonton, Alberta, Canada, T6G 2C8
        • River Valley Health Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Self ambulatory participants with or without acute/chronic LBP. LBP is defined as pain or discomfort between costal margin and above the gluteal folds, with or without leg pain.
  • All the included LBP participants must have modified Oswestry Disability Index score > 12%
  • Have the ability to lie prone for at least 20 minutes.
  • Asymptomatic participants should be free from LBP at the time of visit.

Exclusion Criteria:

  • With medical 'red flag' conditions such as cancer, cauda equine syndrome, spinal infection, fracture or systemic disease
  • History of arm surgery, shoulder or arm pain that may hinder the arm lifting in prone
  • History of orthopedic or neurological surgery to the spine, pelvis or hips
  • Inflammatory or active infective processes involving spine or shoulder
  • Spondylolisthesis, ankylosing spondylitis, scoliosis of greater than 20 degrees (Cobb's angle)
  • Pregnancy
  • Osteoporosis
  • Neurologic deficit or signs of nerve root compression
  • Congenital spinal disorder (such as spina bifida),
  • Participation in competitive sports more than 3 times per week
  • History of spinal manipulation or lumbar multifidus stabilization exercise training within the past 4 weeks
  • Additional exclusion criteria for asymptomatic participants include: back pain in the preceding year, or exceeding 1 week; missed at least 1 work day because of back pain; and consultation for a back problem.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SMT for low back pain patients
To investigate the effects of high velocity, low amplitude lumbopelvic spinal manipulative therapy on spinal stiffness and back muscle activity.
High velocity, low amplitude spinal manipulative therapy (HVLA-SMT) will be provided to the lumbopelvic region on both sides.
Other Names:
  • spinal manipulation
  • High velocity, low amplitude spinal manipulative therapy
Other: Asymptomatic arm
To investigate the sequential changes in spinal stiffness and back muscle activity of asymptomatic participants over time without any intervention. Participants of this arm can volunteer for an additional experimental pain protocol after their third visit (at 1 week) to investigate the effects of experimental pain on the changes of spinal stiffness and back muscle activity using a randomized crossover design (injecting 5% hypertonic saline or 0.9% isotonic saline to the interspinous ligaments at L3 to L5 levels in random order in two additional visits).
A randomized crossover design is used to investigate the changes in spinal stiffness and back muscle activity of asymptomatic participants following an experimental pain induction procedure. Specifically, asymptomatic participants attend two separate sessions 5 days apart. Participants will receive 0.3 ml of 5% hypertonic saline or 0.9% isotonic saline in random order into the interspinous ligaments at L3 to L5 levels. The resulting temporal changes in pain intensity, spinal stiffness and trunk muscle activity following saline injections will be monitored. During the second session, the participants will undergo the same procedures but with the previously unused saline concentration.
Other: Low back pain participants without SMT
To investigate the temporal changes in lumbar disc diffusion within a 1-hour period without SMT
No treatment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Modified Oswestry Low Back Pain Disability Index
Time Frame: baseline, Day 3, and 1 week
It is a questionnaire to assess the participants' perceived low back pain related functional disability.
baseline, Day 3, and 1 week
Change of 11-point Numeric Pain Rating Scale
Time Frame: baseline, Day 3, and 1 week
It is a scale to measure the perceived pain intensity by the participants.
baseline, Day 3, and 1 week
Change in Body Pain diagram
Time Frame: Baseline, Day 3, and 1 week
The diagram will be used to demarcate the location and area of symptoms
Baseline, Day 3, and 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in measurement of lumbar multifidus muscle thickness by rehabilitative ultrasound imaging
Time Frame: Baseline, Day 3, and 1 week
Using the rehabilitative ultrasound imaging to measure lumbar multifidus muscle thickness at rest and during an automatic muscle contraction.
Baseline, Day 3, and 1 week
Change of spinal stiffness testing by a mechanical indentation machine
Time Frame: Baseline, Day 3, and 1 week
The spinal stiffness of participants will be measured by a validated mechanical indentation machine. Briefly, a 60 N load will be applied to the third lumbar spinous process and the corresponding spinal tissue deformations will be measured. The spinal stiffness will be calculated from the force-displacement curve of each indentation.
Baseline, Day 3, and 1 week
Electromyography of trunk muscles
Time Frame: At the third visit (1 week from the baseline)
Electromyography of abdominal and erector spinae muscles during spinal stiffness testing will be measured.
At the third visit (1 week from the baseline)
Magnetic resonance imaging of lumbar region for participants with low back pain
Time Frame: At the beginning and immediately after the first visit (an expected average of 1 hour apart)
It records the anatomical features of the lumbar spine and the changes in lumbar disc diffusion during the first session (an expected average of 1-hour duration).
At the beginning and immediately after the first visit (an expected average of 1 hour apart)
Fear Avoidance Beliefs Questionnaire
Time Frame: Baseline
It assesses the fear avoidance behaviour of participants
Baseline
Change in Borg Category-Ratio Scale of Perceived Exertion
Time Frame: Baseline, Day 3, and 1 week
It measures the subjective perception of exertion during the spinal stiffness test and muscle testings
Baseline, Day 3, and 1 week
Global Rating Of Change
Time Frame: 1 week after baseline
It measures the perceived change of body function from the first visit.
1 week after baseline

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measurement of lumbar multifidus muscle thickness by rehabilitative ultrasound imaging in the pain induction experiment
Time Frame: Before the injection, immediately after the injection, and 25-minute after the injection in each session
Using the rehabilitative ultrasound imaging to measure lumbar multifidus muscle thickness at rest and during an automatic muscle contraction.
Before the injection, immediately after the injection, and 25-minute after the injection in each session
Spinal stiffness assessment by mechanical indentation machine in the pain induction experiment
Time Frame: Before the injection, immediately after the injection, and 25-minute after the injection in each session
The spinal stiffness of participants will be measured by a validated mechanical indentation machine. Briefly, a 60 N load will be applied to the third lumbar spinous process and the corresponding spinal tissue deformations will be measured. The spinal stiffness will be calculated from the force-displacement curve of each indentation.
Before the injection, immediately after the injection, and 25-minute after the injection in each session
Electromyography of trunk muscles in the pain induction experiment
Time Frame: Before the injection, immediately after the injection, and 25-minute after the injection in each session
Electromyography of abdominal and erector spinae muscles during spinal stiffness testing will be measured.
Before the injection, immediately after the injection, and 25-minute after the injection in each session
11-point Numeric Pain Rating Scale in the pain induction experiment
Time Frame: Before the injection, immediately after the injection, and 25-minute after the injection in each session
It is a scale to measure the perceived pain intensity by the participants.
Before the injection, immediately after the injection, and 25-minute after the injection in each session
Body Pain diagram in the pain induction experiment
Time Frame: Before the injection, immediately after the injection, and 25-minute after the injection in each session
The diagram will be used to demarcate the location and area of symptoms
Before the injection, immediately after the injection, and 25-minute after the injection in each session
Modified Oswestry low back pain disability index in the pain induction experiment
Time Frame: Before the injection in each session
It is a questionnaire to assess the participants' perceived low back pain related functional disability.
Before the injection in each session
Fear of Pain Questionnaire - III in the pain induction experiment
Time Frame: Before the injection in the first session
It measures the perceived fear of pain under different hypothetical painful experiences.
Before the injection in the first session
Fear Avoidance Beliefs Questionnaire in the pain induction experiment
Time Frame: Before the injection in the first session
It assesses the fear avoidance behaviour of participants
Before the injection in the first session
Borg Category-Ratio Scale of Perceived Exertion in the pain induction experiment
Time Frame: Before the injection, immediately after the injection, and 25-minute after the injection in each session
It measures the subjective perception of exertion during the spinal stiffness test and muscle testings
Before the injection, immediately after the injection, and 25-minute after the injection in each session

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gregory N Kawchuk, PhD, DC, Department of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

October 1, 2014

Study Registration Dates

First Submitted

January 2, 2013

First Submitted That Met QC Criteria

January 3, 2013

First Posted (Estimate)

January 7, 2013

Study Record Updates

Last Update Posted (Estimate)

August 11, 2015

Last Update Submitted That Met QC Criteria

August 9, 2015

Last Verified

August 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on SMT for low back pain patients

3
Subscribe